Voyager Therapeutics, Inc.
VYGR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640266
No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Voyager Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- −4 vs. Q3 2023
- Shares held
- 27.0M
- −278.9K (−1.0%) vs. Q3 2023
- Total value
- $227.5M
- +$16.4M (+7.7%) vs. Q3 2023
- New holders
- 19
- 31 more added
- Sold out
- 23
- 31 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $122.7M |
| Q1 2026 | 135 | $129.4M |
| Q4 2025 | 125 | $132.6M |
| Q3 2025 | 117 | $141.1M |
| Q2 2025 | 113 | $103.1M |
| Q1 2025 | 116 | $117.4M |
| Q4 2024 | 133 | $196.2M |
| Q3 2024 | 128 | $205.9M |
| Q2 2024 | 127 | $301.6M |
| Q1 2024 | 132 | $331.1M |
| Q4 2023 | 107 | $227.5M |
| Q3 2023 | 111 | $211.2M |
| Q2 2023 | 106 | $307.7M |
| Q1 2023 | 82 | $183.8M |
| Q4 2022 | 70 | $146.2M |
| Q3 2022 | 69 | $142.9M |
| Q2 2022 | 78 | $142.3M |
| Q1 2022 | 70 | $171.3M |
| Q4 2021 | 59 | $51.3M |
| Q3 2021 | 69 | $58.6M |
| Q2 2021 | 78 | $96.8M |
| Q1 2021 | 101 | $125.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 1,004,786 | $8.48M | 0.00% | −169,301−14.4% | Reduced |
| Erste Asset Management GmbH | 1,058,378 | $9.00M | 0.13% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 1,292,000 | $10.9M | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,529,668 | $21.4M | 0.00% | +47,711+1.9% | Added |
| BlackRock Inc. | 2,632,679 | $22.2M | 0.00% | +167,291+6.8% | Added |
| EcoR1 Capital, LLC | 3,851,507 | $32.5M | 0.84% | 00.0% | Unchanged |
| Armistice Capital, LLC | 4,236,000 | $35.8M | 0.95% | +58,000+1.4% | Added |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −367,590−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −140,020−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −103,966−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −84,619−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −60,322−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −36,425−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −31,181−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −29,401−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,885−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,600−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −15,083−100.0% | Sold out |
| Ascension Capital Advisors, Inc. | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −14,063−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,262−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,715−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,460−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,085−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,904−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,572−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −3,182−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Optimum Investment Advisors | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |